• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

连续性肾脏替代治疗对危重症患者抗生素药代动力学的影响。

The impact of continuous renal replacement therapy on antibiotic pharmacokinetics in critically ill patients.

机构信息

Department of Intensive Care, Hopital Erasme, Brussels, Belgium.

Department of Infectious Diseases, Hopital Erasme, Brussels, Belgium.

出版信息

Expert Opin Drug Metab Toxicol. 2021 May;17(5):543-554. doi: 10.1080/17425255.2021.1902985. Epub 2021 Mar 28.

DOI:10.1080/17425255.2021.1902985
PMID:33733979
Abstract

: Mortality due to severe infections in critically ill patients undergoing continuous renal replacement therapy (CRRT) remains high. Nevertheless, rapid administration of adequate antibiotic therapy can improve survival. Delivering optimized antibiotic therapy can be a challenge, as standard drug regimens often result in insufficient or excessive serum concentrations due to significant changes in the volume of distribution and/or drug clearance in these patients. Insufficient drug concentrations can be responsible for therapeutic failure and death, while excessive concentrations can cause toxic adverse events.: We performed a narrative review of the impact of CRRT on the pharmacokinetics of the most frequently used antibiotics in critically ill patients. We have provided explanations for the changes in the PKs of antibiotics observed and suggestions to optimize dosage regimens in these patients.: Despite considerable efforts to identify optimal antibiotic dosage regimens for critically ill patients receiving CRRT, adequate target achievement remains too low for hydrophilic antibiotics in many patients. Whenever possible, individualized therapy based on results from therapeutic drug monitoring must be given to avoid undertreatment or toxicity.

摘要

: 在接受连续肾脏替代治疗 (CRRT) 的重症感染患者中,严重感染导致的死亡率仍然很高。然而,快速给予足够的抗生素治疗可以提高生存率。由于这些患者的分布容积和/或药物清除率发生显著变化,标准药物方案往往导致血清浓度不足或过高,因此提供优化的抗生素治疗可能具有挑战性。药物浓度不足可能导致治疗失败和死亡,而浓度过高则会引起毒性不良反应。: 我们对 CRRT 对重症患者最常用抗生素药代动力学的影响进行了叙述性综述。我们对观察到的抗生素药代动力学变化进行了解释,并为这些患者的剂量方案优化提供了建议。: 尽管为确定接受 CRRT 的重症患者的最佳抗生素剂量方案做出了相当大的努力,但在许多患者中,亲水性抗生素的靶目标达标率仍然太低。在可能的情况下,必须根据治疗药物监测的结果进行个体化治疗,以避免治疗不足或毒性。

相似文献

1
The impact of continuous renal replacement therapy on antibiotic pharmacokinetics in critically ill patients.连续性肾脏替代治疗对危重症患者抗生素药代动力学的影响。
Expert Opin Drug Metab Toxicol. 2021 May;17(5):543-554. doi: 10.1080/17425255.2021.1902985. Epub 2021 Mar 28.
2
How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy?对于接受不同类型肾脏替代治疗的重症患者,我们如何确保有效的抗生素给药剂量?
Diagn Microbiol Infect Dis. 2015 May;82(1):92-103. doi: 10.1016/j.diagmicrobio.2015.01.013. Epub 2015 Feb 2.
3
Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy.脓毒性休克合并持续肾脏替代治疗的危重症患者的β-内酰胺类药物给药
Crit Care. 2014 Jun 23;18(3):227. doi: 10.1186/cc13938.
4
Antibiotic Dosing for Critically Ill Adult Patients Receiving Intermittent Hemodialysis, Prolonged Intermittent Renal Replacement Therapy, and Continuous Renal Replacement Therapy: An Update.重症成人患者接受间歇性血液透析、延长间歇性肾脏替代治疗和持续肾脏替代治疗时的抗生素剂量:更新。
Ann Pharmacother. 2020 Jan;54(1):43-55. doi: 10.1177/1060028019865873. Epub 2019 Jul 25.
5
Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.接受肾脏替代治疗患者抗菌治疗的药代动力学考量
Clin Pharmacokinet. 2007;46(12):997-1038. doi: 10.2165/00003088-200746120-00003.
6
Optimizing ceftaroline dosing in critically ill patients undergoing continuous renal replacement therapy.优化接受连续肾脏替代治疗的危重症患者的头孢洛林剂量。
Pharmacotherapy. 2021 Feb;41(2):205-211. doi: 10.1002/phar.2502. Epub 2021 Feb 7.
7
Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.β-内酰胺类抗生素治疗药物监测对连续性肾脏替代治疗危重症患者剂量调整的影响。
Int J Antimicrob Agents. 2017 May;49(5):589-594. doi: 10.1016/j.ijantimicag.2017.01.009. Epub 2017 Mar 21.
8
Harmonizing antibiotic regimens with renal replacement therapy.调整抗生素方案与肾脏替代治疗的协同作用。
Expert Rev Anti Infect Ther. 2020 Sep;18(9):887-895. doi: 10.1080/14787210.2020.1764845. Epub 2020 May 18.
9
Therapeutic Drug Monitoring of Antibiotic Drugs in Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis: A Critical Review.连续肾脏替代治疗或间歇性血液透析患者中抗生素药物的治疗药物监测:批判性评价。
Ther Drug Monit. 2022 Feb 1;44(1):86-102. doi: 10.1097/FTD.0000000000000941.
10
Population Pharmacokinetics of Tigecycline for Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.替加环素在接受连续肾脏替代治疗的危重症患者中的群体药代动力学。
Drug Des Devel Ther. 2024 Oct 5;18:4459-4469. doi: 10.2147/DDDT.S473080. eCollection 2024.

引用本文的文献

1
Pharmacokinetic Research in Pediatric Extracorporeal Therapies: Current State and Future Directions.儿科体外治疗中的药代动力学研究:现状与未来方向。
Blood Purif. 2024 Jun;53(6):520-526. doi: 10.1159/000534828. Epub 2024 Feb 28.
2
Risk Factors Associated with Antibiotic Exposure Variability in Critically Ill Patients: A Systematic Review.危重症患者抗生素暴露变异性的相关危险因素:一项系统评价
Antibiotics (Basel). 2024 Aug 24;13(9):801. doi: 10.3390/antibiotics13090801.
3
Understanding antimicrobial pharmacokinetics in critically ill patients to optimize antimicrobial therapy: A narrative review.
了解重症患者的抗菌药物药代动力学以优化抗菌治疗:一篇叙述性综述。
J Intensive Med. 2024 Feb 29;4(3):287-298. doi: 10.1016/j.jointm.2023.12.007. eCollection 2024 Jul.
4
Antimicrobial Pharmacokinetics and Pharmacodynamics in Critical Care: Adjusting the Dose in Extracorporeal Circulation and to Prevent the Genesis of Multiresistant Bacteria.重症监护中的抗菌药物药代动力学与药效学:体外循环中的剂量调整及多耐药菌的预防
Antibiotics (Basel). 2023 Feb 27;12(3):475. doi: 10.3390/antibiotics12030475.